Corrosion protection of aluminium alloys by sol-gel coatings

[ES] En el presente trabajo se estudia la protección frente a la corrosión que proporcionan tres nuevos recubrimientos nanoméricos de baja temperatura de curado obtenidos a partir de silanos modificados. La síntesis de estos recubrimientos se realiza a partir de una mezcla de dos soles, GPTS (glicidoxipropiltrimetoxisilano) prehidrolizado y un segundo sol TEOS/MTES. Añadiendo a este sol inicial una disolución coloidal de partículas se obtienen recubrimientos nanoméricos de mayor espesor. En el presente trabajo los recubrimientos particulados se obtuvieron incorporando un 25% en peso de partículas comerciales de SiO2, Aerosil 300 y Aerosil R972 respectivamente. Una vez sintetizados, se depositaron mediante el método de centrifugado, sobre dos aleaciones de aluminio, 5555 y 3005 empleadas como substratos. El espesor final de los recubrimientos es de orden de 10 ìm, para el recubrimiento sin partículas y algo superiores, 12-14 ìm aproximadamente, para los recubrimientos con partículas. Los resultados electroquímicos indicaron que, en todos los casos, las muestras recubiertas presentaban una mejora en el comportamiento frente a la corrosión respecto de los substratos sin recubrir. La velocidad de corrosión disminuye 3 órdenes de magnitud para los recubrimientos con partículas y ésta disminución es algo inferior para aquellos que no contienen partículas.[EN] Present paper studies the corrosion protection of three new nanomeric coatings obtained from modified silanes and cured at low temperatures. The synthesis of these coatings is carried out starting from a mixture of two sols separately prepared: a prehydrolized GPTS (glicidoxipropiltrimetoxisilano) and a second sol TEOS/MTES. Adding to this initial sol a colloidal solution of 25% in weight of commercial particles of SiO2, Aerosil 300 and Aerosil R972 respectively can be obtained thicker nanomeric coatings. Once synthesized, they were deposited by means of the spin coating method onto two aluminum alloys, 5555 and 3005 used as substrates. The final thickness of the coatings is about 10 μm, for the coating without particles and slightly higher, 12-14 μm approximately, for the coatings with particles. The electrochemical results indicated that, in all cases, the coated samples presented an improvement in the corrosion behavior in comparison with bare alloys in aggressive media of NaCl. The corrosion rate decreased three orders of magnitude for the coatings with particles and lower for those that do not contain particles.Los autores quieren agradecer al proyecto BRITE BE-5111: "High Performance protection with sol-gel coatings on metals and enamels" por financiar parte de este estudio.Peer reviewe

Sol-gel coatings for protection and bioactivation of metals used in orthopaedic devices

The aim of this work is the production and characterisation of sol-gel coatings for protection and bioactivation of metals used as standard surgical implant materials, such as stainless steel 316 L (ASTM F138), Co based alloys (ASTM F75) and titanium alloy Ti-6A1-4V (ASTM F67). These films should both prevent degradation of the substrates by wear or corrosion, and bioactivate the material for inducing the formation of a hydroxyapatite (HA) rich layer onto the material surface, thereby permitting a natural bonding to living tissues. Formation of HA layers can be observed on performing in vitro tests by soaking the material in simulated body solutions. The work describes the development of coatings containing bioactive glass and glass-ceramic particles in hybrid methyl-triethoxysilane (MTES) and tetraethylorthosilicate (TEOS) acidic sol, applied by dip-coating to surgical alloys, AISI 316 L, ASTM F75 and ASTM 67, with the aim of accomplishing both high corrosion resistance of the metal in the body environment and adhesion of the implant to the surrounding tissue. The performance of the coated metal was evaluated in vitro by electrochemical techniques including potentiodynamic polarisation curves and electrochemical impedance spectroscopy, to follow the formation of hydroxyapatite on the surface, as well as the in vitro release of ions by plasma atomic emission spectroscopy (ICP-MS) after up to one year of immersion. In vivo behaviour was evaluated by subcutaneous tests and endomedullar implantation in Hokaido rats to study possible rejection reactions and natural bonding to living tissue.Peer Reviewe

Metodología ApS: una herramienta poderosa en la transferencia de competencias de la academia a la sociedad que contribuye a la humanización del Sistema Sanitario español y la atención sanitaria de poblaciones vulnerables

Fac. de FarmaciaTRUEOficina Universitaria ApS UCMsubmitte

Clustering COVID-19 ARDS patients through the first days of ICU admission. An analysis of the CIBERESUCICOVID Cohort

Background Acute respiratory distress syndrome (ARDS) can be classified into sub-phenotypes according to different inflammatory/clinical status. Prognostic enrichment was achieved by grouping patients into hypoinflammatory or hyperinflammatory sub-phenotypes, even though the time of analysis may change the classification according to treatment response or disease evolution. We aimed to evaluate when patients can be clustered in more than 1 group, and how they may change the clustering of patients using data of baseline or day 3, and the prognosis of patients according to their evolution by changing or not the cluster.Methods Multicenter, observational prospective, and retrospective study of patients admitted due to ARDS related to COVID-19 infection in Spain. Patients were grouped according to a clustering mixed-type data algorithm (k-prototypes) using continuous and categorical readily available variables at baseline and day 3.Results Of 6205 patients, 3743 (60%) were included in the study. According to silhouette analysis, patients were grouped in two clusters. At baseline, 1402 (37%) patients were included in cluster 1 and 2341(63%) in cluster 2. On day 3, 1557(42%) patients were included in cluster 1 and 2086 (57%) in cluster 2. The patients included in cluster 2 were older and more frequently hypertensive and had a higher prevalence of shock, organ dysfunction, inflammatory biomarkers, and worst respiratory indexes at both time points. The 90-day mortality was higher in cluster 2 at both clustering processes (43.8% [n = 1025] versus 27.3% [n = 383] at baseline, and 49% [n = 1023] versus 20.6% [n = 321] on day 3). Four hundred and fifty-eight (33%) patients clustered in the first group were clustered in the second group on day 3. In contrast, 638 (27%) patients clustered in the second group were clustered in the first group on day 3.Conclusions During the first days, patients can be clustered into two groups and the process of clustering patients may change as they continue to evolve. This means that despite a vast majority of patients remaining in the same cluster, a minority reaching 33% of patients analyzed may be re-categorized into different clusters based on their progress. Such changes can significantly impact their prognosis

The evolution of the ventilatory ratio is a prognostic factor in mechanically ventilated COVID-19 ARDS patients

Background: Mortality due to COVID-19 is high, especially in patients requiring mechanical ventilation. The purpose of the study is to investigate associations between mortality and variables measured during the first three days of mechanical ventilation in patients with COVID-19 intubated at ICU admission. Methods: Multicenter, observational, cohort study includes consecutive patients with COVID-19 admitted to 44 Spanish ICUs between February 25 and July 31, 2020, who required intubation at ICU admission and mechanical ventilation for more than three days. We collected demographic and clinical data prior to admission; information about clinical evolution at days 1 and 3 of mechanical ventilation; and outcomes. Results: Of the 2,095 patients with COVID-19 admitted to the ICU, 1,118 (53.3%) were intubated at day 1 and remained under mechanical ventilation at day three. From days 1 to 3, PaO2/FiO2 increased from 115.6 [80.0-171.2] to 180.0 [135.4-227.9] mmHg and the ventilatory ratio from 1.73 [1.33-2.25] to 1.96 [1.61-2.40]. In-hospital mortality was 38.7%. A higher increase between ICU admission and day 3 in the ventilatory ratio (OR 1.04 [CI 1.01-1.07], p = 0.030) and creatinine levels (OR 1.05 [CI 1.01-1.09], p = 0.005) and a lower increase in platelet counts (OR 0.96 [CI 0.93-1.00], p = 0.037) were independently associated with a higher risk of death. No association between mortality and the PaO2/FiO2 variation was observed (OR 0.99 [CI 0.95 to 1.02], p = 0.47). Conclusions: Higher ventilatory ratio and its increase at day 3 is associated with mortality in patients with COVID-19 receiving mechanical ventilation at ICU admission. No association was found in the PaO2/FiO2 variation

Geodivulgar: Geología y Sociedad 2018

Depto. de Geodinámica, Estratigrafía y PaleontologíaFac. de Ciencias GeológicasFALSEsubmitte

Geodivulgar: Geología y Sociedad

Con el lema “Geología para todos” el proyecto Geodivulgar: Geología y Sociedad apuesta por la divulgación de la Geología a todo tipo de público, incidiendo en la importancia de realizar simultáneamente una acción de integración social entre estudiantes y profesores de centros universitarios, de enseñanza infantil, primaria, de educación especial y un acercamiento con público con diversidad funcional

Clonal chromosomal mosaicism and loss of chromosome Y in elderly men increase vulnerability for SARS-CoV-2

The pandemic caused by severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2, COVID-19) had an estimated overall case fatality ratio of 1.38% (pre-vaccination), being 53% higher in males and increasing exponentially with age. Among 9578 individuals diagnosed with COVID-19 in the SCOURGE study, we found 133 cases (1.42%) with detectable clonal mosaicism for chromosome alterations (mCA) and 226 males (5.08%) with acquired loss of chromosome Y (LOY). Individuals with clonal mosaic events (mCA and/or LOY) showed a 54% increase in the risk of COVID-19 lethality. LOY is associated with transcriptomic biomarkers of immune dysfunction, pro-coagulation activity and cardiovascular risk. Interferon-induced genes involved in the initial immune response to SARS-CoV-2 are also down-regulated in LOY. Thus, mCA and LOY underlie at least part of the sex-biased severity and mortality of COVID-19 in aging patients. Given its potential therapeutic and prognostic relevance, evaluation of clonal mosaicism should be implemented as biomarker of COVID-19 severity in elderly people. Among 9578 individuals diagnosed with COVID-19 in the SCOURGE study, individuals with clonal mosaic events (clonal mosaicism for chromosome alterations and/or loss of chromosome Y) showed an increased risk of COVID-19 lethality